Liraglutide, a once daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)
RDs play a central role in this process, providing MNT that evolves based on the patients clinical response, dietary intake, muscle mass, and tolerance to medication.50,51 Before initiating GLP-1 therapy, clinicians should assess baseline diet, medical conditions, disordered eating patterns, and social determinants of health to identify barriers and tailor care.19 Ongoing monitoring should include changes in weight, muscle strength, and nutrient intake, using flexible care delivery models such as telehealth, group visits, or Food is Medicine programs to improve access and equity to nutrient dense foods.19 MNT Recommendations To support long-term success, lifestyle interventions must be structured and ongoing
Convenient : Daily supplements are easier to incorporate into your routine than weekly or monthly injections
Arrival was slow Shipping took way longer than expected this time, but the product quality is still consistent
Without those pieces, the number alone is incomplete
Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology
![LinkInBio] 💊⚕️ Prescription control talk heats up 🧬 The IMA urges “specialist-only” scripts for GLP-1 weight-loss drugs amid misuse and cheap generic frenzy 💭 Should weight-loss meds be treated like serious therapies](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3926801438161027282)
